NCT01054651View on ClinicalTrials.gov

A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni

PHASE3CompletedINTERVENTIONAL

Enrollment

212

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Schistosoma Mansoni

Interventions

DRUG

Artesunate+Sulfamethoxypyrazine/pyrimethamine

DRUG

Praziquantel

Trial Locations (1)

Unknown

KEMRI Centre for Global Health Research, Kisumu

Sponsors

Lead Sponsor

Kenya Medical Research Institute

Collaborators (1)

All Listed Sponsors

collaborator

Dafra Pharma

INDUSTRY

lead

Kenya Medical Research Institute

OTHER